Featured Research

from universities, journals, and other organizations

Genetic signature identified for leading cause of infant hospitalizations worldwide

Date:
November 14, 2013
Source:
Nationwide Children's Hospital
Summary:
Scientists have identified the genetic signature of respiratory syncytial virus (RSV), the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could allow physicians to determine the severity of the infection when symptoms first develop.

Scientists have identified the genetic signature of respiratory syncytial virus (RSV), the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could allow physicians to determine the severity of the infection when symptoms first develop. The study, from a team at The Research Institute at Nationwide Children's Hospital, was published this week in PLOS Medicine.

Related Articles


The World Health Organization estimates that as many as 64 million children worldwide are infected with RSV at any given time. Although most infections result in mild, cold- or flu-like symptoms, RSV can lead to pneumonia or bronchiolitis, landing more than 144,000 infants and children in the hospital each year in the U.S. alone.

"Despite the disease burden, there is no approved vaccine and it is impossible to predict which patients will go on to develop more serious symptoms and require hospitalization," says Asuncion Mejias, MD, PhD, principal investigator in the Center for Vaccines and Immunity at Nationwide Children's and a co-lead author of the new study. "The ability to identify which patients are at risk for severe RSV disease when they first present for treatment would enable physicians to better triage patients, providing early and more targeted interventions."

One of the chief obstacles of managing infants with RSV infection is the lack of a diagnostic tool to predict which patients will develop a more severe illness that requires more aggressive interventions. For this study, Dr. Mejias and colleagues compared the RNA profiles -- also called biosignatures -- from 220 children under 2 years of age who were either healthy or hospitalized with RSV or other respiratory viruses such as influenza or human rhinovirus, which causes the common cold but can also cause bronchiolitis.

They found that in patients with RSV, genes involved in the function of interferon and neutrophils -- key components of the innate immune system -- were activated, while genes that regulate T and B cells in the adaptive immune system were suppressed. The researchers plugged this biosignature into an algorithm used to compare the expression of specific genes between patients and healthy controls. The formula yields a score called "molecular distance to health." In the end, Dr. Mejias and her team were able to link specific scores to disease severity. The scores were so precise, in fact, that researchers could tell from the scores how many days RSV-infected infants had required hospitalization or supplemental oxygen.

"We showed that screening RNA profiles is a useful tool from the diagnostic point of view, as it allowed differentiation from influenza and rhinovirus infections with great accuracy," Dr. Mejias says. "It also helps us better understand the pathogenesis of this infection and, more important, to objectively assess disease severity in these patients."

Knowing the molecular distance to health score for RSV patients could soon have a direct application in the clinical setting, Dr. Mejias adds. Tools designed to calculate such scores in emergency rooms -- the first stop for many patients with RSV -- and even in pediatricians' offices are currently under development.

"These novel and affordable tools will have a much faster turn-around time that could facilitate the application of RNA profiles in 'real time' in the clinical setting," says Dr. Mejias, who also is an assistant professor of pediatrics at The Ohio State University College of Medicine. "It may help triage patients when they first present to the emergency room or pediatric office, but it could also be useful for monitoring clinical changes during the course of the disease, with the ultimate goal of predicting clinical outcomes."

The findings also give researchers a better picture of just how the immune system responds to RSV, information vital to the development of a vaccine, says Octavio Ramilo, MD, a co-lead author of the study and chief of the Section of Infectious Diseases at Nationwide Children's.

"We urgently need better treatments for this disease and eventually a vaccine that can prevent RSV infection," says Dr. Ramilo, who also is a professor of pediatrics at The Ohio State University College of Medicine.

Dr. Ramilo is one of many scientists in the Center for Vaccines and Immunity who have spent decades trying to unravel the biological underpinnings of RSV, a virus that remains largely unknown to the general public. Despite its anonymity, RSV leads to one-quarter of all hospitalizations for pneumonia and 70 percent of hospitalizations for bronchiolitis in young children. RSV also causes severe pneumonia in immunocompromised patients and the elderly.

"We need to do a better job educating our patients and their families about RSV and the huge morbidity associated with these infections," he says.


Story Source:

The above story is based on materials provided by Nationwide Children's Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Asuncion Mejias, Blerta Dimo, Nicolas M. Suarez, Carla Garcia, M. Carmen Suarez-Arrabal, Tuomas Jartti, Derek Blankenship, Alejandro Jordan-Villegas, Monica I. Ardura, Zhaohui Xu, Jacques Banchereau, Damien Chaussabel, Octavio Ramilo. Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection. PLoS Medicine, 2013; 10 (11): e1001549 DOI: 10.1371/journal.pmed.1001549

Cite This Page:

Nationwide Children's Hospital. "Genetic signature identified for leading cause of infant hospitalizations worldwide." ScienceDaily. ScienceDaily, 14 November 2013. <www.sciencedaily.com/releases/2013/11/131114113625.htm>.
Nationwide Children's Hospital. (2013, November 14). Genetic signature identified for leading cause of infant hospitalizations worldwide. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2013/11/131114113625.htm
Nationwide Children's Hospital. "Genetic signature identified for leading cause of infant hospitalizations worldwide." ScienceDaily. www.sciencedaily.com/releases/2013/11/131114113625.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins